Surviving Inflammatory Breast Cancer Thanks to Clinical Research

Published November 22, 2014 by American Association for Cancer Research (AACR).
Diagnosed HER2-positive, with stage III inflammatory breast cancer that progressed to metastatic cancer, Kim Alexander turned to an investigational drug called T-DM1 (Kadcyla) which gave her life back. Running time: 2 minutes, 14 seconds.

Previous article: